AKT1 and neoplasm: Ni et al. [44] demonstrated that in prostate cancer, CD44v6 is an important CSCs biomarker and is closely related to tumour cell proliferation, adhesion, invasion, metastasis, chemo- and radio-resistance, EMT induction, and the activation of PI3K/AKT/mTOR and Wnt signalling pathways.